Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Peter Fendler

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2021
Reply: The Importance of an Adequate Surgical Template During Salvage Lymph Node Dissection for Node-Recurrent Prostate CancerWolfgang Peter Fendler, Andrea Farolfi
Current Opinion in Urology|August 1, 2020
Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrenceJustin Ferdinandus, Wolfgang Peter Fendler, Boris Hadaschik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2016
Variations in PET/MRI Operations: Results from an International Survey Among 39 Active SitesWolfgang Peter Fendler, Johannes Czernin, Ken Herrmann, et al.
European Journal of Radiology|August 14, 2021
Theranostics in oncology: What radiologists want to knowJustin Ferdinandus, Wolfgang Peter Fendler, Joshua James Morigi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2022
Response to letter to the editorDavid Kersting, Miriam Sraieb, Wolfgang Peter Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2018
Reply: Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its WayJeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, et al.
JAMA Network Open|November 16, 2022
FDG-PET Positivity and Overall Survival in Renal Cell CarcinomaJustin Ferdinandus, Ines Maríc, Christopher Darr, et al.
Nuklearmedizin. Nuclear Medicine|March 14, 2018
Effectiveness of Reduced Radioiodine Activity for Thyroid Remnant Ablation after Total Thyroidectomy in Patients with Low to Intermediate Risk Differentiated Thyroid CarcinomaAndrei Todica, Sabine Haidvogl, Wolfgang Peter Fendler, et al.
BMC Cancer|April 18, 2020
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from <sup>68</sup>Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficientManuel Weber, Lukas Kessler, Benedikt Schaarschmidt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2013
High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathologyWolfgang Peter Fendler, Henriette Ingrid Melzer, Christoph Walz, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2021
Reply: The Importance of an Adequate Surgical Template During Salvage Lymph Node Dissection for Node-Recurrent Prostate CancerWolfgang Peter Fendler, Andrea Farolfi
Current Opinion in Urology|August 1, 2020
Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrenceJustin Ferdinandus, Wolfgang Peter Fendler, Boris Hadaschik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2016
Variations in PET/MRI Operations: Results from an International Survey Among 39 Active SitesWolfgang Peter Fendler, Johannes Czernin, Ken Herrmann, et al.
European Journal of Radiology|August 14, 2021
Theranostics in oncology: What radiologists want to knowJustin Ferdinandus, Wolfgang Peter Fendler, Joshua James Morigi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2022
Response to letter to the editorDavid Kersting, Miriam Sraieb, Wolfgang Peter Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 3, 2018
Reply: Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its WayJeremie Calais, Wolfgang Peter Fendler, Ken Herrmann, et al.
JAMA Network Open|November 16, 2022
FDG-PET Positivity and Overall Survival in Renal Cell CarcinomaJustin Ferdinandus, Ines Maríc, Christopher Darr, et al.
Nuklearmedizin. Nuclear Medicine|March 14, 2018
Effectiveness of Reduced Radioiodine Activity for Thyroid Remnant Ablation after Total Thyroidectomy in Patients with Low to Intermediate Risk Differentiated Thyroid CarcinomaAndrei Todica, Sabine Haidvogl, Wolfgang Peter Fendler, et al.
BMC Cancer|April 18, 2020
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from <sup>68</sup>Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficientManuel Weber, Lukas Kessler, Benedikt Schaarschmidt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 17, 2013
High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathologyWolfgang Peter Fendler, Henriette Ingrid Melzer, Christoph Walz, et al.
Pageof 6